_id
6919f14f3c536f8df23185dc
Ticker
5CV.XETRA
Name
CureVac NV
Exchange
XETRA
Address
Friedrich-Miescher-Strasse 15, Tübingen, Germany, 72076
Country
Germany
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.curevac.com
Description
As of December 18, 2025, CureVac N.V. was acquired by BioNTech SE. CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In addition, the company offers The RNA Printer, a downsized, integrated, and highly automated process for manufacturing of mRNA vaccines and therapeutics. Further, it develops prophylactic vaccine lead candidate that addresses urinary tract infections targeting uropathogenic E. coli (UPEC) bacteria; vaccine candidates CV0601 and CV0701, which are in phase 2 clinical study against SARS-CoV-2; vaccines for off-the-shelf and fully personalized cancer precision immunotherapies in oncology; and CVGBM for treating cancer. Additionally, the company develops, manufactures, and commercializes mRNA vaccines targeting SARS-CoV-2 variants; antigen cancer precision immunotherapy candidate that targets squamous non-small cell lung cancer; and antigen cancer precision immunotherapy candidate CVGBM that is tested in patients with surgically resected MGMT-unmethylated glioblastoma or astrocytoma with a molecular signature of glioblastoma. CureVac N.V. was incorporated in 2000 and is headquartered in Tübingen, Germany.
Last Close
3.616
Volume
30323
Current Price
3.906
Change
0.11061946902654876
Last Updated
2025-12-30T11:51:07.320Z
Image
https://logo.clearbit.com/www.curevac.com
Ipo Date
-
Market Cap
824610880
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
493902000
Cost Of Revenue
-21931000
Gross Profit
472971000
Operating Expenses
-32612000
Operating Income
368379000
Interest Expense
141000
Pretax Income
370572000
Net Income
338043000
Eps
1.5012600520168402
Dividends Per Share
-
Shares Outstanding
225172749
Income Tax Expense
-32529000
EBITDA
-
Operating Margin
74.58544407595029
Total Other Income Expense Net
-35377000
Cash
416090000
Short Term Investments
3123000
Receivables
19599000
Inventories
541000
Total Current Assets
873111000
Property Plant Equipment
235603000
Total Assets
1138619000
Payables
8715000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
267389000
Equity
871230000
Bs_currency_symbol
EUR
Depreciation
4360000
Change In Working Capital
-287417000
Cash From Operations
29861000
Capital Expenditures
322000
Cash From Investing
-
Cash From Financing
-1289000
Net Change In Cash
28250000
Cf_currency_symbol
EUR
PE
6.2345
PB
1.0095211831341897
ROE
38.80066113425846
ROA
29.68885992592781
FCF
29539000
Fcf Percent
0.059807411186834636
Piotroski FScore
3
Health Score
79
Deep Value Investing Score
10
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
10
Garp Investing Score
7.5
Growth Investing Score
6
Momentum Investing Score
4
Net Net Investing Score
5
Quality Investing Score
10
Value Investing Score
10
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
493902000
Quarters > 0 > income Statement > cost Of Revenue
-21931000
Quarters > 0 > income Statement > gross Profit
472971000
Quarters > 0 > income Statement > operating Expenses
-32612000
Quarters > 0 > income Statement > operating Income
368379000
Quarters > 0 > income Statement > interest Expense
141000
Quarters > 0 > income Statement > pretax Income
370572000
Quarters > 0 > income Statement > net Income
338043000
Quarters > 0 > income Statement > eps
1.5012600520168402
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
225172847
Quarters > 0 > income Statement > income Tax Expense
-32529000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
74.58544407595029
Quarters > 0 > income Statement > total Other Income Expense Net
-35377000
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
416090000
Quarters > 0 > balance Sheet > short Term Investments
3123000
Quarters > 0 > balance Sheet > receivables
19599000
Quarters > 0 > balance Sheet > inventories
541000
Quarters > 0 > balance Sheet > total Current Assets
873111000
Quarters > 0 > balance Sheet > property Plant Equipment
235603000
Quarters > 0 > balance Sheet > total Assets
1138619000
Quarters > 0 > balance Sheet > payables
8715000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
267389000
Quarters > 0 > balance Sheet > equity
871230000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
273229000
Quarters > 0 > cash Flow > depreciation
4360000
Quarters > 0 > cash Flow > change In Working Capital
-287417000
Quarters > 0 > cash Flow > cash From Operations
29861000
Quarters > 0 > cash Flow > capital Expenditures
322000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-1289000
Quarters > 0 > cash Flow > net Change In Cash
28250000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
1.5012600520168402
Quarters > 0 > ratios > PB
1.0095211831341897
Quarters > 0 > ratios > ROE
38.80066113425846
Quarters > 0 > ratios > ROA
29.68885992592781
Quarters > 0 > ratios > FCF
29539000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.059807411186834636
Quarters > 0 > health Score
79
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
1245000
Quarters > 1 > income Statement > cost Of Revenue
2213000
Quarters > 1 > income Statement > gross Profit
-968000
Quarters > 1 > income Statement > operating Expenses
60778000
Quarters > 1 > income Statement > operating Income
-61746000
Quarters > 1 > income Statement > interest Expense
565000
Quarters > 1 > income Statement > pretax Income
-59966000
Quarters > 1 > income Statement > net Income
-59560000
Quarters > 1 > income Statement > eps
-0.26450791378056343
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
225172847
Quarters > 1 > income Statement > income Tax Expense
-406000
Quarters > 1 > income Statement > EBITDA
-54993000
Quarters > 1 > income Statement > operating Margin
-4959.518072289157
Quarters > 1 > income Statement > total Other Income Expense Net
1780000
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
392703000
Quarters > 1 > balance Sheet > short Term Investments
3111000
Quarters > 1 > balance Sheet > receivables
7702000
Quarters > 1 > balance Sheet > inventories
541000
Quarters > 1 > balance Sheet > total Current Assets
419777000
Quarters > 1 > balance Sheet > property Plant Equipment
238411000
Quarters > 1 > balance Sheet > total Assets
688880000
Quarters > 1 > balance Sheet > payables
7581000
Quarters > 1 > balance Sheet > short Term Debt
4885000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
102513000
Quarters > 1 > balance Sheet > equity
586367000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-59966000
Quarters > 1 > cash Flow > depreciation
4408000
Quarters > 1 > cash Flow > change In Working Capital
12476000
Quarters > 1 > cash Flow > cash From Operations
-42062000
Quarters > 1 > cash Flow > capital Expenditures
1555000
Quarters > 1 > cash Flow > cash From Investing
-1555000
Quarters > 1 > cash Flow > cash From Financing
-1309000
Quarters > 1 > cash Flow > net Change In Cash
-45628000
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.26450791378056343
Quarters > 1 > ratios > PB
1.4999567512871632
Quarters > 1 > ratios > ROE
-10.15746111223858
Quarters > 1 > ratios > ROA
-8.645918011845314
Quarters > 1 > ratios > FCF
-43617000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-35.033734939759036
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
893000
Quarters > 2 > income Statement > cost Of Revenue
875000
Quarters > 2 > income Statement > gross Profit
18000
Quarters > 2 > income Statement > operating Expenses
54745000
Quarters > 2 > income Statement > operating Income
-54727000
Quarters > 2 > income Statement > interest Expense
333000
Quarters > 2 > income Statement > pretax Income
-51655000
Quarters > 2 > income Statement > net Income
-52084000
Quarters > 2 > income Statement > eps
-0.23132987599010454
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
225150339
Quarters > 2 > income Statement > income Tax Expense
429000
Quarters > 2 > income Statement > EBITDA
-46745000
Quarters > 2 > income Statement > operating Margin
-6128.443449048153
Quarters > 2 > income Statement > total Other Income Expense Net
3072000
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
438331000
Quarters > 2 > balance Sheet > short Term Investments
3756000
Quarters > 2 > balance Sheet > receivables
10764000
Quarters > 2 > balance Sheet > inventories
541000
Quarters > 2 > balance Sheet > total Current Assets
469100000
Quarters > 2 > balance Sheet > property Plant Equipment
240986000
Quarters > 2 > balance Sheet > total Assets
742267000
Quarters > 2 > balance Sheet > payables
9428000
Quarters > 2 > balance Sheet > short Term Debt
5198000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
95578000
Quarters > 2 > balance Sheet > equity
646689000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-51655000
Quarters > 2 > cash Flow > depreciation
4577000
Quarters > 2 > cash Flow > change In Working Capital
5814000
Quarters > 2 > cash Flow > cash From Operations
-41374000
Quarters > 2 > cash Flow > capital Expenditures
511000
Quarters > 2 > cash Flow > cash From Investing
-511000
Quarters > 2 > cash Flow > cash From Financing
-1312000
Quarters > 2 > cash Flow > net Change In Cash
-43417000
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-0.23132987599010454
Quarters > 2 > ratios > PB
1.3599075044325788
Quarters > 2 > ratios > ROE
-8.053948652288813
Quarters > 2 > ratios > ROA
-7.016882065348453
Quarters > 2 > ratios > FCF
-41885000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-46.9036954087346
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
14469000
Quarters > 3 > income Statement > cost Of Revenue
1486000
Quarters > 3 > income Statement > gross Profit
12983000
Quarters > 3 > income Statement > operating Expenses
56742000
Quarters > 3 > income Statement > operating Income
-43759000
Quarters > 3 > income Statement > interest Expense
636000
Quarters > 3 > income Statement > pretax Income
-38561000
Quarters > 3 > income Statement > net Income
-32761000
Quarters > 3 > income Statement > eps
-0.14603394195043604
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
224338257
Quarters > 3 > income Statement > income Tax Expense
-5801000
Quarters > 3 > income Statement > EBITDA
-34893000
Quarters > 3 > income Statement > operating Margin
-302.4327873384477
Quarters > 3 > income Statement > total Other Income Expense Net
5198000
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
481748000
Quarters > 3 > balance Sheet > short Term Investments
3622000
Quarters > 3 > balance Sheet > receivables
28140609
Quarters > 3 > balance Sheet > inventories
541146
Quarters > 3 > balance Sheet > total Current Assets
526414000
Quarters > 3 > balance Sheet > property Plant Equipment
244652000
Quarters > 3 > balance Sheet > total Assets
802827000
Quarters > 3 > balance Sheet > payables
17272000
Quarters > 3 > balance Sheet > short Term Debt
5321000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
106219000
Quarters > 3 > balance Sheet > equity
696608000
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-38561000
Quarters > 3 > cash Flow > depreciation
4304000
Quarters > 3 > cash Flow > change In Working Capital
-50093000
Quarters > 3 > cash Flow > cash From Operations
-66562000
Quarters > 3 > cash Flow > capital Expenditures
2570000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-1279000
Quarters > 3 > cash Flow > net Change In Cash
-69114000
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.14603394195043604
Quarters > 3 > ratios > PB
1.2579029121715513
Quarters > 3 > ratios > ROE
-4.702931921539804
Quarters > 3 > ratios > ROA
-4.080704809379854
Quarters > 3 > ratios > FCF
-69132000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-4.777939042089986
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
535180000
Annuals > 0 > income Statement > cost Of Revenue
105829000
Annuals > 0 > income Statement > gross Profit
429351000
Annuals > 0 > income Statement > operating Expenses
251669000
Annuals > 0 > income Statement > operating Income
177682000
Annuals > 0 > income Statement > interest Expense
866213
Annuals > 0 > income Statement > pretax Income
190881000
Annuals > 0 > income Statement > net Income
162186000
Annuals > 0 > income Statement > eps
0.7199627114129711
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
225270000
Annuals > 0 > income Statement > income Tax Expense
28695000
Annuals > 0 > income Statement > EBITDA
209690000
Annuals > 0 > income Statement > operating Margin
33.20041855076797
Annuals > 0 > income Statement > total Other Income Expense Net
13199000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
481748000
Annuals > 0 > balance Sheet > short Term Investments
3622000
Annuals > 0 > balance Sheet > receivables
32902000
Annuals > 0 > balance Sheet > inventories
541000
Annuals > 0 > balance Sheet > total Current Assets
526414000
Annuals > 0 > balance Sheet > property Plant Equipment
244652000
Annuals > 0 > balance Sheet > total Assets
802827000
Annuals > 0 > balance Sheet > payables
17272000
Annuals > 0 > balance Sheet > short Term Debt
10643439
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
106219000
Annuals > 0 > balance Sheet > equity
696608000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
190881000
Annuals > 0 > cash Flow > depreciation
18809000
Annuals > 0 > cash Flow > change In Working Capital
-163963000
Annuals > 0 > cash Flow > cash From Operations
101851000
Annuals > 0 > cash Flow > capital Expenditures
18444000
Annuals > 0 > cash Flow > cash From Investing
-18444000
Annuals > 0 > cash Flow > cash From Financing
-5114000
Annuals > 0 > cash Flow > net Change In Cash
79296000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.7199627114129711
Annuals > 0 > ratios > PB
1.1648194393403464
Annuals > 0 > ratios > ROE
23.282247691671643
Annuals > 0 > ratios > ROA
20.201861671318976
Annuals > 0 > ratios > FCF
83407000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.15584849957023805
Annuals > 0 > health Score
89
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
53758000
Annuals > 1 > income Statement > cost Of Revenue
124366000
Annuals > 1 > income Statement > gross Profit
-70608000
Annuals > 1 > income Statement > operating Expenses
203599000
Annuals > 1 > income Statement > operating Income
-274207000
Annuals > 1 > income Statement > interest Expense
2493000
Annuals > 1 > income Statement > pretax Income
-259969000
Annuals > 1 > income Statement > net Income
-260167000
Annuals > 1 > income Statement > eps
-1.1781150495207762
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
220833271
Annuals > 1 > income Statement > income Tax Expense
198000
Annuals > 1 > income Statement > EBITDA
-234090000
Annuals > 1 > income Statement > operating Margin
-510.07663975594323
Annuals > 1 > income Statement > total Other Income Expense Net
14238000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
402452000
Annuals > 1 > balance Sheet > short Term Investments
2661000
Annuals > 1 > balance Sheet > receivables
39510000
Annuals > 1 > balance Sheet > inventories
24801000
Annuals > 1 > balance Sheet > total Current Assets
478381000
Annuals > 1 > balance Sheet > property Plant Equipment
278625000
Annuals > 1 > balance Sheet > total Assets
788249000
Annuals > 1 > balance Sheet > payables
48033000
Annuals > 1 > balance Sheet > short Term Debt
5005000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
271308000
Annuals > 1 > balance Sheet > equity
516941000
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-260167000
Annuals > 1 > cash Flow > depreciation
23386000
Annuals > 1 > cash Flow > change In Working Capital
-68290000
Annuals > 1 > cash Flow > cash From Operations
-267887000
Annuals > 1 > cash Flow > capital Expenditures
55200000
Annuals > 1 > cash Flow > cash From Investing
-55200000
Annuals > 1 > cash Flow > cash From Financing
230893000
Annuals > 1 > cash Flow > net Change In Cash
-93345000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-1.1781150495207762
Annuals > 1 > ratios > PB
1.5387470565151533
Annuals > 1 > ratios > ROE
-50.3281805854053
Annuals > 1 > ratios > ROA
-33.005687289168776
Annuals > 1 > ratios > FCF
-323087000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-6.010026414673165
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
67420000
Annuals > 2 > income Statement > cost Of Revenue
183993000
Annuals > 2 > income Statement > gross Profit
-116573000
Annuals > 2 > income Statement > operating Expenses
134279000
Annuals > 2 > income Statement > operating Income
-249457000
Annuals > 2 > income Statement > interest Expense
3707000
Annuals > 2 > income Statement > pretax Income
-249155000
Annuals > 2 > income Statement > net Income
-249029000
Annuals > 2 > income Statement > eps
-1.3170917213865567
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
189074911
Annuals > 2 > income Statement > income Tax Expense
-126000
Annuals > 2 > income Statement > EBITDA
-209386000
Annuals > 2 > income Statement > operating Margin
-370.0044497181845
Annuals > 2 > income Statement > total Other Income Expense Net
302000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
495797000
Annuals > 2 > balance Sheet > short Term Investments
4487000
Annuals > 2 > balance Sheet > receivables
9002000
Annuals > 2 > balance Sheet > inventories
23989000
Annuals > 2 > balance Sheet > total Current Assets
584029000
Annuals > 2 > balance Sheet > property Plant Equipment
241702000
Annuals > 2 > balance Sheet > total Assets
860472000
Annuals > 2 > balance Sheet > payables
68246000
Annuals > 2 > balance Sheet > short Term Debt
4980000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
327219000
Annuals > 2 > balance Sheet > equity
533253000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-249155000
Annuals > 2 > cash Flow > depreciation
23741000
Annuals > 2 > cash Flow > change In Working Capital
-125563000
Annuals > 2 > cash Flow > cash From Operations
-286177000
Annuals > 2 > cash Flow > capital Expenditures
93222000
Annuals > 2 > cash Flow > cash From Investing
-93499000
Annuals > 2 > cash Flow > cash From Financing
63173000
Annuals > 2 > cash Flow > net Change In Cash
-315667000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-1.3170917213865567
Annuals > 2 > ratios > PB
1.2771570519471995
Annuals > 2 > ratios > ROE
-46.699971683234786
Annuals > 2 > ratios > ROA
-28.940976580295462
Annuals > 2 > ratios > FCF
-379399000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-5.627395431622664
Annuals > 2 > health Score
31
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
102990000
Annuals > 3 > income Statement > cost Of Revenue
238195000
Annuals > 3 > income Statement > gross Profit
-135205000
Annuals > 3 > income Statement > operating Expenses
277058000
Annuals > 3 > income Statement > operating Income
-412263000
Annuals > 3 > income Statement > interest Expense
10338000
Annuals > 3 > income Statement > pretax Income
-412498000
Annuals > 3 > income Statement > net Income
-411716000
Annuals > 3 > income Statement > eps
-2.213377109869329
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
186012586
Annuals > 3 > income Statement > income Tax Expense
-782000
Annuals > 3 > income Statement > EBITDA
-386486000
Annuals > 3 > income Statement > operating Margin
-400.2942033207107
Annuals > 3 > income Statement > total Other Income Expense Net
-235000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
811464000
Annuals > 3 > balance Sheet > short Term Investments
4648000
Annuals > 3 > balance Sheet > receivables
53738000
Annuals > 3 > balance Sheet > inventories
56159000
Annuals > 3 > balance Sheet > total Current Assets
940019000
Annuals > 3 > balance Sheet > property Plant Equipment
200393000
Annuals > 3 > balance Sheet > total Assets
1158242000
Annuals > 3 > balance Sheet > payables
122263000
Annuals > 3 > balance Sheet > short Term Debt
3469000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
469766000
Annuals > 3 > balance Sheet > equity
688476000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-412498000
Annuals > 3 > cash Flow > depreciation
15674000
Annuals > 3 > cash Flow > change In Working Capital
-69547000
Annuals > 3 > cash Flow > cash From Operations
-733128000
Annuals > 3 > cash Flow > capital Expenditures
127901000
Annuals > 3 > cash Flow > cash From Investing
-127901000
Annuals > 3 > cash Flow > cash From Financing
344964000
Annuals > 3 > cash Flow > net Change In Cash
-511129000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-2.213377109869329
Annuals > 3 > ratios > PB
0.9731890941325478
Annuals > 3 > ratios > ROE
-59.80106786583701
Annuals > 3 > ratios > ROA
-35.546630151557274
Annuals > 3 > ratios > FCF
-861029000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-8.36031653558598
Annuals > 3 > health Score
30
Valuation > metrics > PE
6.2345
Valuation > metrics > PB
1.0095211831341897
Valuation > final Score
100
Valuation > verdict
18.8% Undervalued
Profitability > metrics > ROE
38.80066113425846
Profitability > metrics > ROA
38.7170703381357
Profitability > metrics > Net Margin
0.68443334912594
Profitability > final Score
100
Profitability > verdict
Adequate
Risk > metrics > Debt Equity
0.3069097712429554
Risk > metrics > Interest Coverage
2612.6170212765956
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
100.18485370051636
Liquidity > metrics > Quick Ratio
100.122776821572
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-377
Prev Risks > 1
-597
Prev Risks > 2
-215
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-24T18:45:01.236Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-09
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.09
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-12
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
1.21
Earnings History > 1 > eps Estimate
-0.07
Earnings History > 1 > eps Difference
1.28
Earnings History > 1 > surprise Percent
1828.5714
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-19
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.18
Earnings History > 2 > eps Estimate
-0.18
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
0
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-20
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
-0.2313
Earnings History > 3 > eps Estimate
-0.1612
Earnings History > 3 > eps Difference
-0.0701
Earnings History > 3 > surprise Percent
-43.4864
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.146
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
1.5009
Earnings History > 5 > eps Estimate
1.41
Earnings History > 5 > eps Difference
0.0909
Earnings History > 5 > surprise Percent
6.4468
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-15
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.3234
Earnings History > 6 > eps Estimate
-0.2807
Earnings History > 6 > eps Difference
-0.0427
Earnings History > 6 > surprise Percent
-15.212
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-23
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.3146
Earnings History > 7 > eps Estimate
-0.1858
Earnings History > 7 > eps Difference
-0.1288
Earnings History > 7 > surprise Percent
-69.3219
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-12
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.3869
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-14
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
-0.22
Earnings History > 9 > eps Estimate
-0.22
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
0
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-17
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.3
Earnings History > 10 > eps Estimate
-0.3
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
0
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-04-25
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.675
Earnings History > 11 > eps Estimate
-0.68
Earnings History > 11 > eps Difference
0.005
Earnings History > 11 > surprise Percent
0.7353
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2022-12-31
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
-0.6604
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-16
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.25
Earnings History > 13 > eps Estimate
-0.25
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
0
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-18
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.31
Earnings History > 14 > eps Estimate
-0.31
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
0
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-04-28
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
-0.02
Earnings History > 15 > eps Estimate
-0.02
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
0
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2021-12-31
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.0103
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-19
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.77
Earnings History > 17 > eps Estimate
-0.71
Earnings History > 17 > eps Difference
-0.06
Earnings History > 17 > surprise Percent
-8.4507
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
-0.825
Earnings History > 18 > eps Estimate
-0.85
Earnings History > 18 > eps Difference
0.025
Earnings History > 18 > surprise Percent
2.9412
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-04-15
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.4
Earnings History > 19 > eps Estimate
-0.515
Earnings History > 19 > eps Difference
0.115
Earnings History > 19 > surprise Percent
22.3301
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-30
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
-0.4122
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.4122
Earnings History > 20 > surprise Percent
-
As of December 18, 2025, CureVac N.V. was acquired by BioNTech SE. CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). The company's portfolio includes clinical and preclinical candidates for various disease indications in prophylactic vaccines, oncology, and molecular therapy. It also delivers optimized mRNAs to stimulate the production of therapeutic proteins utilizing its technology and instructs human cells to produce or secrete specific proteins in the nucleus, cytoplasm, cellular organelles, and cell membrane. In addition, the company offers The RNA Printer, a downsized, integrated, and highly automated process for manufacturing of mRNA vaccines and therapeutics. Further, it develops prophylactic vaccine lead candidate that addresses urinary tract infections targeting uropathogenic E. coli (UPEC) bacteria; vaccine candidates CV0601 and CV0701, which are in phase 2 clinical study against SARS-CoV-2; vaccines for off-the-shelf and fully personalized cancer precision immunotherapies in oncology; and CVGBM for treating cancer. Additionally, the company develops, manufactures, and commercializes mRNA vaccines targeting SARS-CoV-2 variants; antigen cancer precision immunotherapy candidate that targets squamous non-small cell lung cancer; and antigen cancer precision immunotherapy candidate CVGBM that is tested in patients with surgically resected MGMT-unmethylated glioblastoma or astrocytoma with a molecular signature of glioblastoma. CureVac N.V. was incorporated in 2000 and is headquartered in Tübingen, Germany.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very High
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of CureVac NV
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
-0.09
Date
2025-09-30
EPS Actual
1.21
EPS Estimate
-0.07
EPS Difference
1.28
Surprise Percent
1828.5714%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.